KR102254751B1 - New Lactobacillus plantarum WiKim83 and use thereof - Google Patents

New Lactobacillus plantarum WiKim83 and use thereof Download PDF

Info

Publication number
KR102254751B1
KR102254751B1 KR1020200003362A KR20200003362A KR102254751B1 KR 102254751 B1 KR102254751 B1 KR 102254751B1 KR 1020200003362 A KR1020200003362 A KR 1020200003362A KR 20200003362 A KR20200003362 A KR 20200003362A KR 102254751 B1 KR102254751 B1 KR 102254751B1
Authority
KR
South Korea
Prior art keywords
wikim83
lactobacillus plantarum
strain
activity
food
Prior art date
Application number
KR1020200003362A
Other languages
Korean (ko)
Inventor
정지혜
김성현
김수지
이재용
최재원
Original Assignee
한국식품연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원 filed Critical 한국식품연구원
Priority to KR1020200003362A priority Critical patent/KR102254751B1/en
Application granted granted Critical
Publication of KR102254751B1 publication Critical patent/KR102254751B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a novel Lactobacillus plantarum WiKim83 strain and uses thereof. More particularly, the Lactobacillus plantarum WiKim83 strain has antibacterial activity, antioxidant activity and probiotic activity, thereby being usefully used for a pharmaceutical composition, a food composition and the like.

Description

신규의 락토바실러스 플란타럼 WiKim83 균주 및 이의 용도 {New Lactobacillus plantarum WiKim83 and use thereof} New Lactobacillus plantarum WiKim83 strain and use thereof {New Lactobacillus plantarum WiKim83 and use thereof}

본 발명은 김치로부터 분리되어 항균 활성, 항산화 활성 및 프로바이오틱 활성을 갖는 락토바실러스 플란타럼 WiKim83 균주에 관한 것이다.The present invention relates to a Lactobacillus plantarum WiKim83 strain isolated from kimchi and having antibacterial activity, antioxidant activity and probiotic activity.

유산균은 원유 또는 유가공품을 유산균으로 발효시킨 것으로 정의하고 있으며, 발효유는 완전식품인 원유에 유산균 스타터(starter)를 첨가하여 일정한 온도에서 발효시켜 제조되며, 스타터에 사용되는 유산균은 주로 Lactobacillus acidophilus, Bifidobacteria, Streptococcus thermophilus가 있으며, 대부분이 프로바이오틱스(probiotics)에 해당된다.Lactobacillus is defined as fermentation of crude milk or dairy products with lactic acid bacteria, and fermented milk is manufactured by fermenting at a constant temperature by adding a lactic acid bacteria starter to crude milk, which is a complete food. There is Streptococcus thermophilus, most of which are probiotics.

프로바이오틱스는 동물의 장내 유산균의 증식 및 유해균 억제에 도움을 주어 장내 환경에 유익한 작용을 하는 균주를 말하는 것으로서, GRAS(Generally Recognized As Safe)로 안전한 미생물이며, 내산성 및 내담즙성을 가짐으로써 위장관에서 살아남아 숙주의 장내에 정착하여 숙주에게 건강적 효능을 주는 것으로 보고되어 있다.Probiotics refers to strains that have a beneficial effect on the intestinal environment by helping to proliferate and inhibit harmful bacteria in the intestine of animals.It is a safe microorganism as GRAS (Generally Recognized As Safe), and survives in the gastrointestinal tract by having acid resistance and bile resistance. It is reported to settle in the intestine of the host and give the host a health effect.

프로바이오틱스의 효능으로는 항생제 관련 설사, 병원성 균에 의한 장의 감염, 과민성 대장 증후군 같은 위장관질환 개선, 아토피 피부염 감소, 고혈압 개선, 혈중 콜레스테롤 수준 감소 및 혈중 지질상태 개선, 항비만효과, 대장암과 위암에 대한 항암 효과 등 다양한 기능성에 대한 연구가 진행되고 있다. The efficacy of probiotics includes antibiotic-related diarrhea, intestinal infection by pathogenic bacteria, improvement of gastrointestinal diseases such as irritable bowel syndrome, reduction of atopic dermatitis, improvement of hypertension, reduction of blood cholesterol level and improvement of blood lipid status, anti-obesity effect, and colon cancer and stomach cancer. Research on various functionalities such as anticancer effect is being conducted.

유산균을 포함하는 식품으로는 김치, 청국장, 된장, 요구르트 등으로 다양한데, 그 중 한국 전통 발효식품인 김치는 가장 쉽게 접할 수 있는 식품으로서, 김치의 발효과정에서 다양하고 풍부한 유산균이 발생하여 프로바이오틱스 균주의 보고라 할 수 있다. 김치 내에는 여러 락토바실러스 (Lactobacillus), 비피도박테리움 (Bifidobacterium), 류코노스톡 (Leuconostoc), 페디오코커스 (Pediococcus), 스트렙토코커스 (Streptococcus) 속 등의 미생물이 존재하며, 이들은 김치의 발효와 숙성과정에서 중요한 역할을 담당한다. 김치의 효능에 대한 연구를 통해 다양한 건강 기능성이 보고되어 있으며, 김치 유산균을 이용한 다양한 식품들이 개발되고 있다.Foods containing lactic acid bacteria include kimchi, cheonggukjang, miso, and yogurt. Among them, kimchi, a traditional fermented food in Korea, is the most easily accessible food. It can be called a report. In kimchi, there are several microorganisms such as Lactobacillus, Bifidobacterium, Leuconostoc, Pediococcus, and Streptococcus, and these are the fermentation and fermentation of kimchi. It plays an important role in the aging process. Various health functions have been reported through studies on the efficacy of kimchi, and various foods using kimchi lactic acid bacteria are being developed.

한편, 노화에 의해 인체 내에 과도한 활성산소가 생성되면 단백질의 변성, 지질의 산화, DNA의 손상을 일으켜 암이나 동맥경화, 당뇨병과 같은 여러 질병이 생기게 된다. 항산화 효과를 지닌 식품 및 성분은 인체 내 활성산소를 제거하여 이러한 질병을 예방 및 치료 할 수 있는 것으로 알려져 있다.On the other hand, when excessive free radicals are generated in the human body due to aging, protein denaturation, lipid oxidation, and DNA damage are caused, leading to various diseases such as cancer, arteriosclerosis, and diabetes. It is known that foods and ingredients with antioxidant effects can prevent and treat these diseases by removing free radicals from the human body.

따라서, 한국 전통 발효식품인 김치로부터 항산화 등과 같은 인체에 유익한 다양한 기능성을 가지면서 프로바이오틱스로서의 필요한 활성을 갖는 신규한 프로바이오틱 균주에 대한 연구는 현재의 시점에서 매우 필요한 것이라 할 수 있다.Therefore, it can be said that a study on a novel probiotic strain having a necessary activity as a probiotic while having various functions beneficial to the human body such as antioxidants from kimchi, a traditional Korean fermented food, is very necessary at the present time.

한국특허공개 제2004-0012717호Korean Patent Publication No. 2004-0012717 한국특허등록 제2,033,439호Korean Patent Registration No. 2,033,439 한국특허등록 제2,028,744호Korean Patent Registration No. 2,028,744 한국특허등록 제177,287호Korean Patent Registration No. 177,287

따라서, 본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로서, 본 발명의 해결하고자 하는 과제는 프로바이오틱스로서 필요한 활성과 동시에 항산화 활성 및 항균 활성을 갖는 신규 유산균을 제공하는데 그 목적이 있다.Accordingly, the present invention has been devised to solve the above problems, and an object to be solved of the present invention is to provide a novel lactic acid bacterium having antioxidant activity and antibacterial activity as well as required activity as probiotics.

또한, 본 발명은 상기 신규 유산균의 다양한 용도를 제공하는데 그 목적이 있다.In addition, an object of the present invention is to provide various uses of the novel lactic acid bacteria.

다만, 본 발명에서 이루고자 하는 기술적 과제들은 이상에서 언급한 기술적 과제들로 제한되지 않으며, 언급하지 않은 또 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.However, the technical problems to be achieved in the present invention are not limited to the technical problems mentioned above, and other technical problems that are not mentioned are clearly to those of ordinary skill in the technical field to which the present invention belongs from the following description. It will be understandable.

상기한 기술적 과제를 달성하기 위하여, 본 발명은 항균 활성, 항산화 활성 및 프로바이오틱 활성을 갖는 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주를 제공한다.In order to achieve the above technical problem, the present invention provides a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain having antibacterial activity, antioxidant activity and probiotic activity.

일 실시예에 있어서, 상기 항균 활성은 식중독균에 대한 항균 활성을 갖는 것일 수 있다.In one embodiment, the antimicrobial activity may be one having antimicrobial activity against food poisoning bacteria.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물, 상기 배양물의 농축액 및 상기 배양물의 건조물로 이루어진 군에서 선택된 하나 이상을 유효성분으로 포함하는 식품 조성물을 제공한다.In addition, the present invention provides a food composition comprising one or more selected from the group consisting of a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof, a concentrate of the culture, and a dried product of the culture as an active ingredient. do.

일 실시예에 있어서, 상기 식품 조성물은 기능성 음료, 건강기능 식품, 김치 접종제 또는 발표 식품일 수 있다.In one embodiment, the food composition may be a functional beverage, a health functional food, a kimchi inoculum, or a presentation food.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물을 유효성분으로 포함하는 프로바이오틱 조성물을 제공한다.In addition, the present invention provides a probiotic composition comprising a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof as an active ingredient.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물을 유효성분으로 포함하고 활성산소로 인해 발생하는 질환을 예방 또는 치료하기 위한 약학 조성물을 제공한다. In addition, the present invention provides a pharmaceutical composition for preventing or treating diseases caused by free radicals comprising the Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof as an active ingredient.

본 발명에 따른 락토바실러스 플란타럼 WiKim83는 장내생존성, 장 상피세포 부착능, 소수성, 응집성이 우수하여 개체에 경구투여시 대부분이 장에 도달할 수 있고, 장내에서 유해균의 번식을 효과적으로 억제할 수 있기 때문에 프로바이오틱 소재로 유용하게 사용될 수 있는 이점이 있다,Lactobacillus plantarum WiKim83 according to the present invention has excellent intestinal viability, intestinal epithelial cell adhesion, hydrophobicity, and cohesiveness, so that most of them can reach the intestine when administered orally to an individual, and effectively inhibit the propagation of harmful bacteria in the intestine. Because it can be used, there is an advantage that it can be usefully used as a probiotic material.

또한, 본 발명에 따른 락토바실러스 플란타럼 WiKim83는 항균 활성, 베타-갈락토시다제(β-galactosidase) 활성이 우수하여 젖당 불내증(lactose intolerance)을 예방 또는 개선하는데 유용한 식품 및 의약품 소재로 유용하게 사용될 수 있는 이점이 있다.In addition, the Lactobacillus plantarum WiKim83 according to the present invention has excellent antibacterial activity and beta-galactosidase activity, making it useful as a food and pharmaceutical material useful for preventing or improving lactose intolerance. There are advantages that can be used.

또한, 본 발명에 따른 락토바실러스 플란타럼 WiKim83는 항균 활성, 및 항산화 활성이 우수하여 산화 작용 및 미생물 감염에 의해 유발되는 질환의 예방, 개선 또는 치료를 위한 식품 및 의약품 소재로 유용하게 사용될 수 있는 이점이 있다.In addition, the Lactobacillus plantarum WiKim83 according to the present invention has excellent antibacterial activity and antioxidant activity, so that it can be usefully used as a food and pharmaceutical material for the prevention, improvement or treatment of diseases caused by oxidation and microbial infection. There is an advantage.

다만, 본 발명에서 얻을 수 있는 효과는 이상에서 언급한 효과들로 제한되지 않으며, 언급하지 않은 또 다른 효과들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.However, the effects obtainable in the present invention are not limited to the above-mentioned effects, and other effects not mentioned will be clearly understood by those of ordinary skill in the art from the following description. I will be able to.

도 1은 본 발명에 따른 상기 락토바실러스 플란타럼 WiKim83 균의 염기서열 목록을 나타낸 것이다.1 shows a list of the nucleotide sequence of the Lactobacillus plantarum WiKim83 bacteria according to the present invention.

아래에서는 첨부한 도면을 참고로 하여 본 발명의 실시예에 대하여 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명에 관한 설명은 구조적 내지 기능적 설명을 위한 실시예에 불과하므로, 본 발명의 권리범위는 본문에 설명된 실시예에 의하여 제한되는 것으로 해석되어서는 아니 된다. 즉, 실시예는 다양한 변경이 가능하고 여러 가지 형태를 가질 수 있으므로 본 발명의 권리범위는 기술적 사상을 실현할 수 있는 균등물들을 포함하는 것으로 이해되어야 한다. 또한, 본 발명에서 제시된 목적 또는 효과는 특정 실시예가 이를 전부 포함하여야 한다거나 그러한 효과만을 포함하여야 한다는 의미는 아니므로, 본 발명의 권리범위는 이에 의하여 제한되는 것으로 이해되어서는 아니 될 것이다.Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those of ordinary skill in the art may easily implement the present invention. However, since the description of the present invention is merely an embodiment for structural or functional description, the scope of the present invention should not be construed as being limited by the embodiments described in the text. That is, since the embodiments can be variously changed and have various forms, the scope of the present invention should be understood to include equivalents capable of realizing the technical idea. In addition, since the object or effect presented in the present invention does not mean that a specific embodiment should include all or only such effects, the scope of the present invention should not be understood as being limited thereto.

본 발명에서 서술되는 용어의 의미는 다음과 같이 이해되어야 할 것이다.The meaning of the terms described in the present invention should be understood as follows.

"제1", "제2" 등의 용어는 하나의 구성요소를 다른 구성요소로부터 구별하기 위한 것으로, 이들 용어들에 의해 권리범위가 한정되어서는 아니 된다. 예를 들어, 제1 구성요소는 제2 구성요소로 명명될 수 있고, 유사하게 제2 구성요소도 제1 구성요소로 명명될 수 있다. 어떤 구성요소가 다른 구성요소에 "연결되어" 있다고 언급된 때에는, 그 다른 구성요소에 직접적으로 연결될 수도 있지만, 중간에 다른 구성요소가 존재할 수도 있다고 이해되어야 할 것이다. 반면에, 어떤 구성요소가 다른 구성요소에 "직접 연결되어" 있다고 언급된 때에는 중간에 다른 구성요소가 존재하지 않는 것으로 이해되어야 할 것이다. 한편, 구성요소들 간의 관계를 설명하는 다른 표현들, 즉 "~사이에"와 "바로 ~사이에" 또는 "~에 이웃하는"과 "~에 직접 이웃하는" 등도 마찬가지로 해석되어야 한다.Terms such as "first" and "second" are used to distinguish one component from other components, and the scope of rights is not limited by these terms. For example, a first component may be referred to as a second component, and similarly, a second component may be referred to as a first component. When a component is referred to as being "connected" to another component, it is to be understood that although it may be directly connected to the other component, another component may exist in the middle. On the other hand, when it is mentioned that a component is "directly connected" to another component, it should be understood that there is no other component in the middle. On the other hand, other expressions describing the relationship between components, that is, "between" and "just between" or "neighboring to" and "directly neighboring to" should be interpreted as well.

단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한 복수의 표현을 포함하는 것으로 이해되어야 하고, "포함하다" 또는 "가지다" 등의 용어는 설시된 특징, 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이며, 하나 또는 그 이상의 다른 특징이나 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.Singular expressions are to be understood as including plural expressions unless the context clearly indicates otherwise, and terms such as "comprises" or "have" refer to the specified features, numbers, steps, actions, components, parts, or these. It is to be understood that it is intended to designate that a combination exists and does not preclude the presence or addition of one or more other features, numbers, steps, actions, components, parts, or combinations thereof.

여기서 사용되는 모든 용어들은 다르게 정의되지 않는 한, 본 발명이 속하는 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가진다. 일반적으로 사용되는 사전에 정의되어 있는 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 것으로 해석되어야 하며, 본 발명에서 명백하게 정의하지 않는 한 이상적이거나 과도하게 형식적인 의미를 지니는 것으로 해석될 수 없다.All terms used herein have the same meaning as commonly understood by one of ordinary skill in the field to which the present invention belongs, unless otherwise defined. Terms defined in commonly used dictionaries should be interpreted as having meanings in the context of related technologies, and cannot be interpreted as having an ideal or excessively formal meaning unless explicitly defined in the present invention.

본 발명은 김치로부터 유래되어, 항균 활성, 항산화 활성 및 프로바이오틱 활성을 갖는 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주에 관한 것이다. The present invention relates to a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain that is derived from kimchi and has antibacterial activity, antioxidant activity and probiotic activity.

상기 락토바실러스 플란타룸은 락토바실러스 속 유산균으로 주로 김치, 우유, 치즈, 버터 등에서 분리되며 자연계에서 가장 분포가 넓은 유산균 중 하나이며, 미국 FDA(Food and Drug Administration)에서 인정한 GRAS(Generally Recognized As Safe) 균주다. 이러한 락토바실러스 플란타룸은 김치가 발효되어 신맛이 날 때 주로 생장하는 균으로 내산성과 내담즙성이 강하며, 푸자리움(Fusarium), 슈도모나스(Pseudomonas)에 대한 항균 활성을 갖고, 항산화 및 항염증 효과를 갖고 있는 것으로 알려져 있다.The Lactobacillus plantarum is a lactic acid bacteria of the genus Lactobacillus and is mainly isolated from kimchi, milk, cheese, butter, etc., and is one of the most widely distributed lactic acid bacteria in nature, and is generally recognized as safe (GRAS) recognized by the US Food and Drug Administration (FDA). ) It is a strain. This Lactobacillus plantarum is a fungus that grows mainly when kimchi is fermented and has a sour taste, has strong acid resistance and bile resistance, has antibacterial activity against Fusarium and Pseudomonas, and has antioxidant and anti-inflammatory properties. It is known to have an effect.

본 발명의 용어 "항균"은 세균이나 진균 등의 미생물의 생장 및 증식을 억제 또는 제어하는 작용을 의미하는 것으로, 본 발명의 락토바실러스 플란타럼 WiKim83 균주는 이에 제한되지는 않으나, 바실러스세레우스(B. cereus), 황색포도상구균(S. aureus), 리스테리아(L. monocytogenes), 클로스트리디움 퍼프린젠스(C. perfringens), 살모넬라 타이피뮤리움(S. Typhimurium), 대장균(E. coli), 장염비브리오(V. parahaemolyticus), 캠필로박터 제주니(C. jejuni), 및 캠필로박터 콜리(C. coli) 등의 식중독균일 수 있다. The term "antibacterial" of the present invention refers to an action of inhibiting or controlling the growth and proliferation of microorganisms such as bacteria or fungi, and the Lactobacillus plantarum WiKim83 strain of the present invention is not limited thereto, but Bacillus cereus ( B. cereus ), Staphylococcus aureus ( S. aureus ), Listeria ( L. monocytogenes ), Clostridium perfringens (C. perfringens ), Salmonella typhimurium ( S. Typhimurium), E. coli ( E. coli ), Enteritis Vibrio ( V. parahaemolyticus ), Campylobacter jejuni (C. jejuni ), and Campylobacter coli ( C. coli ) may be food poisoning bacteria.

본 발명의 용어 "항산화"는 산화를 억제하는 작용을 의미하는 것으로, 인체는 산화촉진물질(prooxidant)과 산화억제물질(antioxidant)이 균형을 이루고 있으나 여러 가지 요인들에 의하여 이런 균형상태가 불균형을 이루게 되고 산화촉진 쪽으로 기울게 되면, 산화적 스트레스(oxidative stress)가 유발되어 잠재적인 세포손상 및 병리적 질환을 일으키게 된다. 이러한 산화적 스트레스의 직접적 원인이 되는 활성산소종(reactive oxygen species, ROS)은 불안정하고 반응성이 높아 여러 생체물질과 쉽게 반응하고, 체내 고분자들을 공격하여 세포와 조직에 비가역적인 손상을 일으키거나 돌연변이, 세포독성 및 발암 등을 초래하게 된다. NO, HNO2, ONOO-와 같은 활성질소종(reactive nitrogen species, RNS)은 염증 반응 시 대식세포 호중구 및 다른 면역 세포들의 면역반응으로 인해 다량 생성되며, 이때 ROS도 같이 생성된다. 상기와 같은 활성산소는 체내에서 세포를 산화시켜 파괴시키며, 그에 따라 각종 질환에 노출되게 된다. The term "antioxidation" of the present invention refers to an action of inhibiting oxidation, and the human body has a balance between an oxidation promoting substance (prooxidant) and an antioxidant substance (antioxidant). When it is achieved and tilted toward the promotion of oxidation, oxidative stress is induced, leading to potential cell damage and pathological diseases. Reactive oxygen species (ROS), which are the direct cause of oxidative stress, are unstable and highly reactive, so they easily react with various biomaterials and attack macromolecules in the body, causing irreversible damage to cells and tissues, or mutations. It leads to cytotoxicity and carcinogenesis. Reactive nitrogen species (RNS) such as NO, HNO 2 and ONOO - are produced in large quantities due to the immune response of macrophage neutrophils and other immune cells during the inflammatory reaction, and ROS is also produced at this time. The active oxygen as described above oxidizes and destroys cells in the body, thereby being exposed to various diseases.

본 발명에 따른 락토바실러스 플란타럼 WiKim83 균주는 DPPH+, ABTS

Figure 112020002688415-pat00001
+ β-Carotene 방법으로 측정을 수행한 결과, 강한 항산화 효과를 나타낸다는 것을 확인하였다. Lactobacillus plantarum WiKim83 strain according to the present invention is DPPH+, ABTS
Figure 112020002688415-pat00001
+ β-As a result of performing the measurement by the Carotene method, it was confirmed that it exhibited a strong antioxidant effect.

본 발명의 용어 “프로바이오틱”은 충분한 양을 투여할 때 숙주의 건강에 유익한, 살아있는 미생물을 말한다. 지금까지 알려져 있는 대부분의 프로바이오틱스는 우리가 흔히 유산균이라고 알고 있는 종류가 거의 대부분이다. 프로바이오틱스로 인정받기 위해서는 위산, 담즙산에서 죽지 않고 소장까지 도달하여 장에서 증식하고 정착하여야 하며 장관 내에서 유익한 효과를 나타내어야 하고 독성이 없으며 병원성이 없어야 한다.The term "probiotic" of the present invention refers to a living microorganism that is beneficial to the health of a host when administered in a sufficient amount. Most of the probiotics known so far are almost all of the types we commonly know as lactobacilli. In order to be recognized as a probiotic, it must reach the small intestine without dying from gastric and bile acids, multiply and settle in the intestine, have a beneficial effect in the intestine, be non-toxic, and have no pathogenicity.

본 발명에 따른 락토바실러스 플란타럼 WiKim83 균주는 장내생존성, 부착능, 소수성, 응집성 및 β-galactosidase 활성 등을 측정하여 프로바이오틱으로서의 잠재성을 확인하였다.The Lactobacillus plantarum WiKim83 strain according to the present invention confirmed its potential as a probiotic by measuring intestinal viability, adhesion, hydrophobicity, aggregation and β-galactosidase activity.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물, 상기 배양물의 농축액 및 상기 배양물의 건조물로 이루어진 군에서 선택된 하나 이상을 유효성분으로 포함하는 식품 조성물을 제공한다.In addition, the present invention provides a food composition comprising one or more selected from the group consisting of a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof, a concentrate of the culture, and a dried product of the culture as an active ingredient. do.

상기 식품 조성물은 식품, 식품첨가제, 음료, 음료첨가제, 발효유 및/또는 건강기능식품 등으로 사용될 수 있으나 이에 한정되는 것은 아니다. 상기 식품은 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및/또는 비타민 복합제 등이 될 수 있으며, 이에 한정되는 것은 아니다. 본 발명의 식품 조성물은 식품학적으로 허용 가능한 담체를 추가로 포함하는 것일 수 있다. The food composition may be used as food, food additives, beverages, beverage additives, fermented milk and/or health functional foods, but is not limited thereto. These foods include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea, drinks, alcoholic beverages and/or vitamin complexes, etc. It may be, but is not limited thereto. The food composition of the present invention may further include a food pharmaceutically acceptable carrier.

구체적으로 상기 식품 조성물은 기능성 음료, 건강기능 식품, 김치 접종제 또는 발효 식품일 수 있다.Specifically, the food composition may be a functional beverage, a health functional food, a kimchi inoculum, or a fermented food.

본 발명에서 "기능성 음료"는 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 포함할 수 있다. 상기의 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 수크로오스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100㎖ 당 일반적으로 약 0.01 내지 10g, 바람직하게는 약 0.01 내지 1g 이나 이에 한정되는 것은 아니다.In the present invention, the "functional beverage" may include various flavoring agents or natural carbohydrates as an additional component, like a conventional beverage. As the natural carbohydrates, monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, natural sweeteners such as dextrin and cyclodextrin, synthetic sweeteners such as saccharin and aspartame may be used. The ratio of the natural carbohydrate is generally about 0.01 to 10 g, preferably about 0.01 to 1 g per 100 ml of the composition of the present invention, but is not limited thereto.

본 발명에서 "건강기능식품"은, 영양 공급 외에도 생체조절 기능이 효율적으로 나타나도록 가공된 의학, 의료 효과가 우수한 식품을 의미한다. 상기 식품은 분말, 과립, 정제, 캡슐, 액상, 및 환제를 포함하는 군에서 선택되는 어느 하나의 제형으로 제조될 수 있으나, 당업계에서 통상적으로 사용되는 제형이라면 제한 없이 사용할 수 있다.In the present invention, "health functional food" refers to a food with excellent medical and medical effects processed so that a bioregulatory function is effectively shown in addition to nutritional supply. The food may be prepared in any one formulation selected from the group including powders, granules, tablets, capsules, liquids, and pills, but any formulation commonly used in the art may be used without limitation.

본 발명에서 "발효 식품"은 요구르트, 커드(curd), 치즈, 발효유, 분유, 우유 기재의 발효 식품, 아이스크림 및/또는 발효 곡물 제품(fermented cereal based product)일 수 있으나 이에 한정되는 것은 아니다.In the present invention, "fermented food" may be yogurt, curd, cheese, fermented milk, powdered milk, fermented food based on milk, ice cream and/or fermented cereal based product, but is not limited thereto.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물을 유효성분으로 포함하는 프로바이오틱 조성물을 제공한다. 상기 프로바이오틱 조성물은 유효성분으로 장 상피세포 부착성, 항균 활성, 베타-갈락토시다제(β-galactosidase) 활성 등의 성질을 갖는 락토바실러스 플란타룸(Lactobacillus plantarum)을 유효성분으로 포함하고 있기 때문에 장내세균총의 정상화, 장 건강의 유지, 면역 기능 개선, 장내 유해세균 억제에 의한 정장작용, 젖당 불내증(lactose intolerance)의 경감, 변비 방지, 혈중 콜레스테롤의 감소, 과민성 대장 증후군, 염증성 장질환, 비만, 변비, 지방간, 알레르기 질환 등의 예방 또는 개선 효과를 가질 수 있다.In addition, the present invention provides a probiotic composition comprising a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof as an active ingredient. The probiotic composition contains as an active ingredient Lactobacillus plantarum, which has properties such as intestinal epithelial cell adhesion, antibacterial activity, and beta-galactosidase activity, as an active ingredient. Because of this, normalization of intestinal flora, maintenance of intestinal health, improvement of immune function, intestinal action by suppression of harmful bacteria in the intestine, reduction of lactose intolerance, prevention of constipation, reduction of blood cholesterol, irritable bowel syndrome, inflammatory bowel disease, Obesity, constipation, fatty liver, may have a preventive or improved effect of allergic diseases.

또한, 본 발명은 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물을 유효성분으로 포함하고 활성산소로 인해 발생하는 질환을 예방 또는 치료하기 위한 약학 조성물을 제공한다. In addition, the present invention provides a pharmaceutical composition for preventing or treating diseases caused by free radicals comprising the Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof as an active ingredient.

상기 약학 조성물은 약제학적으로 허용 가능한 담체, 희석제 또는 부형제를 더 포함할 수 있다. 사용 가능한 담체, 부형제 또는 희석제로는 락토즈, 덱스트로즈, 수크로즈, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로즈, 폴리비닐피롤리돈, 물, 메틸하이드록시 벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유로 이루어진 군에서 선택될 수 있으나 이에 한정되지 않는다.The pharmaceutical composition may further include a pharmaceutically acceptable carrier, diluent or excipient. Usable carriers, excipients or diluents include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, gum acacia, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, undecided It may be selected from the group consisting of vaginal cellulose, polyvinylpyrrolidone, water, methylhydroxy benzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil, but is not limited thereto.

본 발명에 따른 약학 조성물의 제형은 사용방법에 따라 바람직한 형태일 수 있으며, 특히 포유동물에 투여된 후 활성성분의 신속, 지속 또는 지연된 방출을 제공할 수 있도록 당업계에 공지된 방법을 이용하여 제형화 할 수 있다.The formulation of the pharmaceutical composition according to the present invention may be in a preferred form depending on the method of use, and in particular, formulation using a method known in the art to provide rapid, sustained or delayed release of the active ingredient after administration to a mammal. I can be angry.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 범주 및 기술사상 범위내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, preferred embodiments are presented to aid in the understanding of the present invention, but the following examples are only illustrative of the present invention, and it is obvious to those skilled in the art that various changes and modifications are possible within the scope and spirit of the present invention. , It is natural that such modifications and modifications fall within the scope of the appended claims.

실시예 1 : 김치로부터 분리 및 동정Example 1: Separation and identification from kimchi

핸드 블렌더로 김치 샘플을 혼합하고, 멸균 된 거즈로 여과한 후, 2 중량% CaCO3가 함유된 MRS-agar 배지에 도말하고, 37 ℃에서 48 시간 동안 배양하였다. 상기 MRS-agar 배지상의 배양 된 균주 중에서, 산 생성으로 주위에 명확한 구역을 형성하는 균주를 분리하였다. 이후, 콜로니를 형성한 후보 균주들을 분리하고 해당 배지에 계대배양한 후, 해당 균주를 순수분리 하였다.Kimchi samples were mixed with a hand blender, filtered through sterilized gauze, spread on MRS-agar medium containing 2% by weight CaCO3, and incubated at 37° C. for 48 hours. Among the cultivated strains on the MRS-agar medium, a strain forming a clear zone around the production of acid was isolated. Thereafter, candidate strains that formed colonies were isolated and subcultured in the corresponding medium, and then the corresponding strain was purely isolated.

이때, 상기 분리된 균주의 항균 활성을 측정하였다.(웰 확산 분석(well .diffusion assay (Fontana, Cocconcelli, Vignolo, & Saavedra, 2015))At this time, the antimicrobial activity of the isolated strain was measured. (well diffusion assay (Fontana, Cocconcelli, Vignolo, & Saavedra, 2015))

상기 분리된 균주는 25 % (v/v) 글리세롤 스톡에 -80 ℃에서 보존하였으며, 이후 실험 전에 균주를 2회 배양 하였다.The isolated strain was preserved at -80 °C in 25% (v/v) glycerol stock, and the strain was cultured twice before the experiment.

StrainStrain Molecular identificationMolecular identification Similarity (%)Similarity (%) Accession number Accession number WiKim83WiKim83 Lactobacillus plantarumLactobacillus plantarum 99.999.9 MH707244MH707244 GenBank database GenBank database

상기 표 1은 김치로부터 분리된 WiKim83 균의 16S rRNA gene sequencing 분석한 결과, 락토바실러스 플란타럼(Lactobacillus plantarum)과 99.9% 이상의 상동성을 보였다. 이를 통해 WiKim83의 종을 락토바실러스 플란타럼(Lactobacillus plantarum)으로 확정하였다. 이때, 상기 락토바실러스 플란타럼 WiKim83 균의 염기서열은 도 1과 같다.Table 1 shows a result of 16S rRNA gene sequencing analysis of WiKim83 bacteria isolated from kimchi, showing more than 99.9% homology with Lactobacillus plantarum. Through this, the species of WiKim83 was confirmed as Lactobacillus plantarum. At this time, the base sequence of the Lactobacillus plantarum WiKim83 bacteria is as shown in FIG. 1.

상기 균주 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83)는 한국미생물보존센터에 기탁되어, 2019년 10월 31일자로 기탁번호 KFCC11843P를 부여받아 보전중이다.The strain Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83) was deposited with the Korea Microbial Conservation Center, and is being preserved by receiving the deposit number KFCC11843P on October 31, 2019.

실험예 1 : 균주의 안전성 평가Experimental Example 1: Evaluation of the safety of strains

1) 용혈 활성 : 7% 탈섬유소 양 혈액(defibrinated sheep blood)를 포함하는 Columbia blood agarbase(BD)를 사용하여 평가하였다(37 ℃에서 24 시간 동안 항온 처리). 1) Hemolytic activity: It was evaluated using Columbia blood agarbase (BD) containing 7% defibrinated sheep blood (incubated at 37°C for 24 hours).

혈액 한천 배지 내의 콜로니 주변에 클리어런스 영역(clearance zone)이 나타나면 용혈 활성이 양성인 경우를 의미하고 클리어런스 영역(clearance zone)이 나타나지 않으면 용혈 활성이 음성인 경우를 의미한다. 용혈 활성 평가 시 양성 대조 균주로 용혈 활성을 가진 O157 : H7을 사용하였다.If a clearance zone appears around a colony in the blood agar medium, it means that the hemolytic activity is positive, and if the clearance zone does not appear, it means that the hemolytic activity is negative. When evaluating hemolytic activity, O157:H7 having hemolytic activity was used as a positive control strain.

2) 효소 생산2) enzyme production

분리된 균주에 의한 효소 생산을 API ZYM 키트 (BioMerieux)로 평가 하였다. Enzyme production by the isolated strain was evaluated with API ZYM kit (BioMerieux).

L. plantarum WiKim83 L. plantarum WiKim83 HemolysisHemolysis γγ Enzyme†Enzyme† ControlControl 00 Alkaline phosphataseAlkaline phosphatase 00 EsteraseEsterase 00 Esterase lipaseEsterase lipase 00 LipaseLipase 00 Leucine arylamidaseLeucine arylamidase 2020 Valine arylamidaseValine arylamidase 00 Cystine arylamidaseCystine arylamidase 00 TrypsinTrypsin 00 α-Chymotrypsinα-Chymotrypsin 00 Acid phosphataseAcid phosphatase 00 Naphthol-AS-BI-phosphohydrolaseNaphthol-AS-BI-phosphohydrolase 00 α-Galactosidaseα-Galactosidase 00 β-Galactosidaseβ-Galactosidase 2020 β-Glucuronidaseβ-Glucuronidase 00 α-Glucosidaseα-Glucosidase 2020 β-Glucosidaseβ-Glucosidase 2020 N-Acetyl-β-glucosaminidaseN-Acetyl-β-glucosaminidase 2020 α-Mannosidaseα-Mannosidase 00 α-Fucosidaseα-Fucosidase 00 † Amount of enzymes derived from isolated LAB strains according to the API ZYM kit. All values are in nmol.† Amount of enzymes derived from isolated LAB strains according to the API ZYM kit. All values are in nmol.

상기 표 2와 같이 본 발명에 따라 김치로부터 분리된 유산균은 용혈성을 보이지 않고, 특히 발암성 및 돌연변이 유도에 관여하는 β-Glucuronidase 등의 유해 효소를 생성하지 않는다는 것을 확인할 수 있었다.As shown in Table 2, it was confirmed that the lactic acid bacteria isolated from kimchi according to the present invention did not show hemolytic properties, and in particular, did not produce harmful enzymes such as β-Glucuronidase, which are involved in carcinogenicity and mutation induction.

실험예 3 : 프로바이오틱 잠재성Experimental Example 3: Probiotic Potential

상기 표 3은 프로바이오틱 잠재성을 확인하기 위하여, 장내생존성, 부착능, 소수성 및 응집성을 확인하였다.In Table 3, in order to confirm the probiotic potential, intestinal viability, adhesion, hydrophobicity, and cohesiveness were confirmed.

[측정방법][How to measure]

1) 장내생존성: 산내성 [1 N HCl (pH 2.5)], 인공위액 [3 mg/mL 펩신(pH 2.5)] 인공 담즙[0.3% (pH 7.4)]에 대한 내성을 평가1) Intestinal viability: To evaluate acid resistance [1 N HCl (pH 2.5)], artificial gastric juice [3 mg/mL pepsin (pH 2.5)] and artificial bile [0.3% (pH 7.4)]

2) 상피세포에 대한 부착능: Caco-2 cell를 이용하여 확인2) Adhesion to epithelial cells: confirmed using Caco-2 cells

3) 소수성 및 자가 응집성 : Ren et al.(2014) 방법 이용하여 확인3) Hydrophobicity and self-aggregation: confirmed using Ren et al. (2014) method

[수학식 1][Equation 1]

Hydrophobicity(%) = (A0-A1)/A0×100Hydrophobicity(%) = (A0-A1)/A0×100

(상기 식 중, A0는 유산균과 클로로포름 현탁액의 OD600이고 A1은 유산균과 클로로포름 현탁액 반응 후 수용액 층의 OD600임)(In the formula, A0 is the OD 600 lactic acid and chloroform and the suspension was OD 600 A1 being the aqueous solution of lactic acid and chloroform suspension reaction layer)

[수학식 2][Equation 2]

Auto-aggregation(%) = (A0-A1)/A0×100Auto-aggregation(%) = (A0-A1)/A0×100

(상기 식 중, A0는 유산균 배양액 초기 OD600이고 A1은 유산균 배양액을 24시간 실온에서 방치한 후 상등액의 OD600임)(In the above formula, A0 is the initial OD 600 of the lactic acid bacteria culture solution, and A1 is the OD 600 of the supernatant after leaving the lactic acid bacteria culture solution at room temperature for 24 hours)

StrainsStrains Gastrointestinal tract tolerance
(log CFU/mL)
Gastrointestinal tract tolerance
(log CFU/mL)
Adhesion (%)Adhesion (%) Hydrophobicity (%)Hydrophobicity (%) Auto-aggregation (%)Auto-aggregation (%)
InitialInitial AcidAcid Gastric juiceGastric juice Bile saltBile salt L. plantarum WiKim83 L. plantarum WiKim83 9.15 ± 0.059.15 ± 0.05 9.16 ± 0.06 9.16 ± 0.06 8.93 ± 0.268.93 ± 0.26 9.20 ± 0.15 9.20 ± 0.15 77.33 ± 2.0877.33 ± 2.08 50.61 ± 0.7650.61 ± 0.76 93.28 ± 0.01 93.28 ± 0.01 L. rhamnosus GG L. rhamnosus GG 9.14 ± 0.359.14 ± 0.35 8.26 ± 0.088.26 ± 0.08 7.98 ± 0.21 7.98 ± 0.21 9.02 ± 0.10 9.02 ± 0.10 69.25 ± 2.4569.25 ± 2.45 50.70 ± 5.2050.70 ± 5.20 92.00 ± 1.4292.00 ± 1.42 Data are mean ± SD (n = 3).Data are mean ± SD (n = 3).

상기 표 3에서 나타낸 바와 같이 본 발명에 따라 김치로부터 분리된 유산균은 상업용 균주인 L. rhamnosus GG (LGG) 보다 높은 장내 생존을(91% 이상)을 보이고, 상피세포에 대한 부착능이 높았으며, 90% 이상의 소수성을 나타낸다는 것을 확인할 수 있었다.As shown in Table 3, the lactic acid bacteria isolated from kimchi according to the present invention showed higher intestinal survival (91% or more) than the commercial strain, L. rhamnosus GG (LGG), and had high adhesion to epithelial cells, and 90 It was confirmed that it exhibited% or more hydrophobicity.

실험예 3 : 항균 활성Experimental Example 3: Antibacterial activity

[측정방법][How to measure]

항균 측정 : 웰 확산 분석(well .diffusion assay (Fontana, Cocconcelli, Vignolo, & Saavedra, 2015) 방법 이용Antibacterial measurement: using well diffusion assay (Fontana, Cocconcelli, Vignolo, & Saavedra, 2015) method

Indicator microorganismIndicator microorganism Inhibition zone (mm)Inhibition zone (mm) L. plantarum WiKim83 L. plantarum WiKim83 Gentamicin
(30 μg/mL)
Gentamicin
(30 μg/mL)
Gram (+)Gram (+) B. cereusB. cereus 16.76 ± 0.20 16.76 ± 0.20 15.09 ± 0.31 15.09 ± 0.31 S. aureusS. aureus 14.70 ± 0.28 14.70 ± 0.28 7.18 ± 0.01 7.18 ± 0.01 L. monocytogenesL. monocytogenes 8.83 ± 0.218.83 ± 0.21 13.23 ± 0.18 13.23 ± 0.18 C. perfringensC. perfringens 12.52 ± 0.49 12.52 ± 0.49 n.d. 1 nd 1 Gram (-)Gram (-) S. Typhimurium S. Typhimurium 14.00 ± 0.11 14.00 ± 0.11 7.87 ± 0.22 7.87 ± 0.22 E. coliE. coli 13.22 ± 0.28 13.22 ± 0.28 9.68 ± 0.04 9.68 ± 0.04 V. parahaemolyticusV. parahaemolyticus 13.96 ± 0.60 13.96 ± 0.60 12.25 ± 0.53 12.25 ± 0.53 Y. enterocoliticaY. enterocolitica 10.43 ± 0.0810.43 ± 0.08 10.49 ± 0.0410.49 ± 0.04 C. jejuniC. jejuni 12.91 ± 0.18 12.91 ± 0.18 18.54 ± 1.41 18.54 ± 1.41 C. coliC. coli 15.17 ± 0.23 15.17 ± 0.23 13.10 ± 0.45 13.10 ± 0.45 1 n.d., not detected (inhibition zones with values ≤ 7 mm were assumed to be devoid of antimicrobial activity).
Data are mean ± SD (n = 3).
1 nd, not detected (inhibition zones with values ≤ 7 mm were assumed to be devoid of antimicrobial activity).
Data are mean ± SD (n = 3).

상기 표 4는 식중독균 10종에 대한 항균활성을 나타낸 것으로, 본 발명에 따라 김치로부터 분리된 유산균은 식종독균 10종에 대하여 광범위한 활성을 나타낸다는 것을 확인할 수 있었다.Table 4 shows the antibacterial activity against 10 species of food poisoning bacteria, and it was confirmed that the lactic acid bacteria isolated from kimchi according to the present invention exhibited a wide range of activities against 10 species of food poisoning bacteria.

실험예 4 : 항산화 활성Experimental Example 4: Antioxidant activity

유산균 5종에 대한 항산화 활성은 DPPH+, ABTS

Figure 112020002688415-pat00002
+, β-Carotene 방법으로 확인함Antioxidant activity against 5 lactic acid bacteria is DPPH + , ABTS
Figure 112020002688415-pat00002
+ , β- Confirmed by Carotene method

[측정방법][How to measure]

① DPPH 라디칼 소거 활성 (DPPH+) : Riaz Rajoka et al.(2017) 방법 이용① DPPH radical scavenging activity (DPPH + ): Using the method of Riaz Rajoka et al. (2017)

[수학식 3][Equation 3]

DPPH+ (%) = [1 - (Asample / Acontrol)] × 100DPPH + (%) = [1-(A sample / Acontrol)] × 100

(식 중, Acontrol은 아스코르브산이고, Asample은 실시예에서 얻어진 균임) (In the formula, A control is ascorbic acid, and A sample is a bacteria obtained in Examples)

② ABTS 라디칼 양이온 소거능 (ABTS

Figure 112020002688415-pat00003
+): Pieniz, Andreazza, Anghinoni, Camargo 및 Brandelli (2014) 방법 이용② ABTS radical cation scavenging ability (ABTS
Figure 112020002688415-pat00003
+ ): Using the method Pieniz, Andreazza, Anghinoni, Camargo and Brandelli (2014)

[수학식 4][Equation 4]

ABTS

Figure 112020002688415-pat00004
+ (%) = [1 - (Asample / Acontrol)] × 100ABTS
Figure 112020002688415-pat00004
+ (%) = [1-(A sample / A control )] × 100

(식 중, Acontrol은 아스코르브산이고, Asample은 실시예에서 얻어진 균임)(In the formula, A control is ascorbic acid, and A sample is a bacteria obtained in Examples)

β-Carotene 표백 활성 : Kachouri et al. (2015) 방법 이용β- Carotene bleaching activity: Kachouri et al. (2015) use method

[수학식 5][Equation 5]

Figure 112020002688415-pat00005
Figure 112020002688415-pat00005

(식 중, Acontrol, 0hr은 아스코르브산 배양 전 흡광도이고, Acontrol, 2hr은 아스코르브산 50℃에서 2시간 배양 후 흡광도이고, Asample, 0hr은 실시예에서 얻어진 균 배양전 흡광도이며, Asample, 2hr은 실시예에서 얻어진 균 50℃에서 2시간 배양 후 흡광도임) (In the formula, A control, 0hr is the absorbance before ascorbic acid culture, A control, 2hr is the absorbance after 2 hours incubation at 50°C of ascorbic acid, A sample, 0hr is the absorbance before culturing the bacteria obtained in the examples, A sample , 2hr is the absorbance after incubation for 2 hours at 50°C for the bacteria obtained in Example)

Antioxidant activity (%)Antioxidant activity (%) L. plantarum WiKim83 L. plantarum WiKim83 Ascorbic acid (1 mg/mL)Ascorbic acid (1 mg/mL) DPPH+ DPPH + 35.35 ± 3.98 35.35 ± 3.98 99.99 ± 0.10 99.99 ± 0.10 ABTS

Figure 112020002688415-pat00006
+ ABTS
Figure 112020002688415-pat00006
+ 99.05 ± 0.90 99.05 ± 0.90 99.99 ± 0.01 99.99 ± 0.01 β-Carotene β -Carotene 38.27 ± 1.10 38.27 ± 1.10 93.33 ± 0.49 93.33 ± 0.49 Data are mean ± SD (n = 3). Data are mean ± SD (n = 3).

상기 표 5는 항산화 활성을 나타낸 것으로 , 본 발명에 따라 김치로부터 분리된 균은 항산화 활성 지수가 높다는 것을 확인할 수 있었다.Table 5 shows the antioxidant activity, it was confirmed that the bacteria isolated from kimchi according to the present invention had a high antioxidant activity index.

실험예 5: Experimental Example 5: ββ -galactosidase 활성-galactosidase activity

[측정방법][How to measure]

β-galactosidase 활성은 Vidhyasagar & Jeevaratnam (2013) 방법을 이용하여 측정하고 하기 수학식 6에 의해 도출하였다. β- galactosidase activity was measured using the Vidhyasagar & Jeevaratnam (2013) method, and was derived by Equation 6 below.

[수학식 6][Equation 6]

Figure 112020002688415-pat00007
Figure 112020002688415-pat00007

(식 중, A420은 실시예에서 얻어진 균의 420nm에서의 흡광도이고, A550은 실시예에서 얻어진 균의 550nm에서의 흡광도임)(Wherein, A 420 is the absorbance at 420 nm of the bacteria obtained in Examples, and A 550 is the absorbance at 550 nm of the bacteria obtained in Examples)

β-Galactosidase activity (MU)β-Galactosidase activity (MU) L. plantarum WiKim83 L. plantarum WiKim83 L. rhamnosus GG L. rhamnosus GG 3,023 ± 98 3,023 ± 98 1,251 ± 1011,251 ± 101 Data are mean ± SD (n = 3). Data are mean ± SD (n = 3).

본 발명에 따라 김치로부터 분리된 유산균은 β-galactosidase 활성은 3,023 MU로 상업용 균주인 L. rhamnosus GG (LGG) 보다 우수하다는 것을 확인할 수 있었다. It was confirmed that the lactic acid bacteria isolated from kimchi according to the present invention had a β- galactosidase activity of 3,023 MU, which is superior to the commercial strain L. rhamnosus GG (LGG).

<110> Korea Food Research Institute <120> New Lactobacillus plantarum WiKim83 and use thereof <130> A19-005 <140> 10-2020-0003362 <141> 2020-01-09 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1527 <212> DNA <213> Lactobacillus plantarum <400> 1 gctggcggcg tgcctaatac atgcaagtcg aacgaactct ggtattgatt ggtgcttgca 60 tcatgattta catttgagtg agtggcgaac tggtgagtaa cacgtgggaa acctgcccag 120 aagcggggga taacacctgg aaacagatgc taataccgca taacaacttg gaccgcatgg 180 tccgagcttg aaagatggct tcggctatca cttttggatg gtcccgcggc gtattagcta 240 gatggtgggg taacggctca ccatggcaat gatacgtagc cgacctgaga gggtaatcgg 300 ccacattggg actgagacac ggcccaaact cctacgggag gcagcagtag ggaatcttcc 360 acaatggacg aaagtctgat ggagcaacgc cgcgtgagtg aagaagggtt tcggctcgta 420 aaactctgtt gttaaagaag aacatatctg agagtaactg ttcaggtatt gacggtattt 480 aaccagaaag ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg 540 ttgtccggat ttattgggcg taaagcgagc gcaggcggtt ttttaagtct gatgtgaaag 600 ccttcggctc aaccgaagaa gtgcatcgga aactgggaaa cttgagtgca gaagaggaca 660 gtggaactcc atgtgtagcg gtgaaatgcg tagatatatg gaagaacacc agtggcgaag 720 gcggctgtct ggtctgtaac tgacgctgag gctcgaaagt atgggtagca aacaggatta 780 gataccctgg tagtccatac cgtaaacgat gaatgctaag tgttggaggg tttccgccct 840 tcagtgctgc agctaacgca ttaagcattc cgcctgggga gtacggccgc aaggctgaaa 900 ctcaaaggaa ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcta 960 cgcgaagaac cttaccaggt cttgacatac tatgcaaatc taagagatta gacgttccct 1020 tcggggacat ggatacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg 1080 ttaagtcccg caacgagcgc aacccttatt atcagttgcc agcattaagt tgggcactct 1140 ggtgagactg ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc 1200 ttatgacctg ggctacacac gtgctacaat ggatggtaca acgagttgcg aactcgcgag 1260 agtaagctaa tctcttaaag ccattctcag ttcggattgt aggctgcaac tcgcctacat 1320 gaagtcggaa tcgctagtaa tcgcggatca gcatgccgcg gtgaatacgt tcccgggcct 1380 tgtacacacc gcccgtcaca ccatgagagt ttgtaacacc caaagtcggt ggggtaacct 1440 tttaggaacc agccgcctaa ggtgggacag atgattaggg tgaagtcgta acaaggtagc 1500 cgtaggagaa cctgcggctg gataccc 1527 <110> Korea Food Research Institute <120> New Lactobacillus plantarum WiKim83 and use thereof <130> A19-005 <140> 10-2020-0003362 <141> 2020-01-09 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1527 <212> DNA <213> Lactobacillus plantarum <400> 1 gctggcggcg tgcctaatac atgcaagtcg aacgaactct ggtattgatt ggtgcttgca 60 tcatgattta catttgagtg agtggcgaac tggtgagtaa cacgtgggaa acctgcccag 120 aagcggggga taacacctgg aaacagatgc taataccgca taacaacttg gaccgcatgg 180 tccgagcttg aaagatggct tcggctatca cttttggatg gtcccgcggc gtattagcta 240 gatggtgggg taacggctca ccatggcaat gatacgtagc cgacctgaga gggtaatcgg 300 ccacattggg actgagacac ggcccaaact cctacgggag gcagcagtag ggaatcttcc 360 acaatggacg aaagtctgat ggagcaacgc cgcgtgagtg aagaagggtt tcggctcgta 420 aaactctgtt gttaaagaag aacatatctg agagtaactg ttcaggtatt gacggtattt 480 aaccagaaag ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg 540 ttgtccggat ttattgggcg taaagcgagc gcaggcggtt ttttaagtct gatgtgaaag 600 ccttcggctc aaccgaagaa gtgcatcgga aactgggaaa cttgagtgca gaagaggaca 660 gtggaactcc atgtgtagcg gtgaaatgcg tagatatatg gaagaacacc agtggcgaag 720 gcggctgtct ggtctgtaac tgacgctgag gctcgaaagt atgggtagca aacaggatta 780 gataccctgg tagtccatac cgtaaacgat gaatgctaag tgttggaggg tttccgccct 840 tcagtgctgc agctaacgca ttaagcattc cgcctgggga gtacggccgc aaggctgaaa 900 ctcaaaggaa ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcta 960 cgcgaagaac cttaccaggt cttgacatac tatgcaaatc taagagatta gacgttccct 1020 tcggggacat ggatacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg 1080 ttaagtcccg caacgagcgc aacccttatt atcagttgcc agcattaagt tgggcactct 1140 ggtgagactg ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc 1200 ttatgacctg ggctacacac gtgctacaat ggatggtaca acgagttgcg aactcgcgag 1260 agtaagctaa tctcttaaag ccattctcag ttcggattgt aggctgcaac tcgcctacat 1320 gaagtcggaa tcgctagtaa tcgcggatca gcatgccgcg gtgaatacgt tcccgggcct 1380 tgtacacacc gcccgtcaca ccatgagagt ttgtaacacc caaagtcggt ggggtaacct 1440 tttaggaacc agccgcctaa ggtgggacag atgattaggg tgaagtcgta acaaggtagc 1500 cgtaggagaa cctgcggctg gataccc 1527

Claims (6)

항균 활성, 항산화 활성 및 프로바이오틱 활성을 갖는 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주에 있어서,
상기 락토바실러스 플란타럼 WiKim83균주는 김치에서 분리되고,
장내생존성, 장상피세포 부착능, 소수성 및 응집성이 우수하며,
용혈성을 보이지 않고,
유해 효소인 β-Glucuronidase를 생성하지 않으며,
베타-갈락토시다제(β-galactosidase) 활성이 우수하며,
유산균 스타터에 사용되며,
상기 항균 활성은 바실러스세레우스(B. cereus), 클로스트리디움 퍼프린젠스
(C. perfringens), 살모넬라 타이피뮤리움(S. Typhimurium), 장염비브리오(V. parahaemolyticus), 여시니아엔테로콜리티카 (Yersinia enterocolitica), 캠필로박터 제주니(C. jejuni), 캠필로박터콜리(C. coli)로 이루어진 군에서 선택된 어느하나 이상에 대한 항균 활성인것을 특징으로 하는,
락토바실러스 플란타럼 WiKim83 균주.


In the Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain having antibacterial activity, antioxidant activity and probiotic activity,
The Lactobacillus plantarum WiKim83 strain is isolated from kimchi,
Excellent intestinal viability, intestinal epithelial cell adhesion, hydrophobicity and cohesiveness,
Does not show hemolytic properties,
It does not produce the harmful enzyme β-Glucuronidase,
It has excellent beta-galactosidase activity,
It is used for lactic acid bacteria starter,
The antimicrobial activity is Bacillus cereus (B. cereus), Clostridium perfringens
(C. perfringens), S. Typhimurium, V. parahaemolyticus, Yersinia enterocolitica, C. jejuni, Campylobacter coli (C. coli) Characterized in that antibacterial activity against any one or more selected from the group consisting of
Lactobacillus plantarum WiKim83 strain.


삭제delete 락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물, 상기 배양물의 농축액 및 상기 배양물의 건조물로 이루어진 군에서 선택된 하나 이상을 유효성분으로 포함하는 식품 조성물.
A food composition comprising one or more selected from the group consisting of a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof, a concentrate of the culture, and a dried product of the culture as an active ingredient.
청구항 3에 있어서, 상기 식품 조성물은 기능성 음료, 건강기능 식품, 김치 접종제 또는 발효 식품인 것을 특징으로 하는 식품 조성물.
The food composition according to claim 3, wherein the food composition is a functional beverage, a health functional food, a kimchi inoculum, or a fermented food.
락토바실러스 플란타럼 WiKim83(Lactobacillus plantarum WiKim83, KFCC11843P) 균주 또는 이의 배양물을 유효성분으로 포함하는 프로바이오틱 조성물.
A probiotic composition comprising a Lactobacillus plantarum WiKim83 (Lactobacillus plantarum WiKim83, KFCC11843P) strain or a culture thereof as an active ingredient.
삭제delete
KR1020200003362A 2020-01-09 2020-01-09 New Lactobacillus plantarum WiKim83 and use thereof KR102254751B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200003362A KR102254751B1 (en) 2020-01-09 2020-01-09 New Lactobacillus plantarum WiKim83 and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200003362A KR102254751B1 (en) 2020-01-09 2020-01-09 New Lactobacillus plantarum WiKim83 and use thereof

Publications (1)

Publication Number Publication Date
KR102254751B1 true KR102254751B1 (en) 2021-05-24

Family

ID=76152701

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200003362A KR102254751B1 (en) 2020-01-09 2020-01-09 New Lactobacillus plantarum WiKim83 and use thereof

Country Status (1)

Country Link
KR (1) KR102254751B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102457366B1 (en) * 2021-09-30 2022-10-21 한국식품연구원 Lactobacillus plantarum wikim0127 strain derived from jeju pickled cabbage food and method for preparing composition using same
KR102457367B1 (en) * 2021-09-30 2022-10-24 한국식품연구원 Lactobacillus plantarum wikim0126 strain derived from jeju pickled brussels sprout food and method for preparing composition using same
KR20230172285A (en) * 2022-06-15 2023-12-22 콜마비앤에이치 주식회사 Novel Lactiplantibacillus plantarum SKO-001 and use thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0177287B1 (en) 1995-09-29 1999-03-20 와다 아키히로 Intake cooling structure in engine room
KR20040012717A (en) 2001-01-25 2004-02-11 발리오 리미티드 Combination of probiotics
KR20120023480A (en) * 2010-08-16 2012-03-13 건국대학교 산학협력단 (a novel lactobacillus plantarum, composition with antibacterial and antioxidant activity comprising the same and use of thereof
KR20180128367A (en) * 2018-11-19 2018-12-03 대구대학교 산학협력단 Kimchi containing fermentation composition using novel lactic acid bacteria Lactobacillus plantarum DGK-17(KACC 81028BP) isolated from Kimchi
KR101960189B1 (en) * 2017-10-25 2019-03-19 건국대학교 산학협력단 NOVEL STRAIN OF Lactobacillus plantarum AND USE THEREOF
KR20190103755A (en) * 2018-02-28 2019-09-05 건국대학교 산학협력단 Novel Lactobacillus plantarum strain and Uses thereof
KR102028744B1 (en) 2018-07-23 2019-10-07 주식회사한국야쿠르트 Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0177287B1 (en) 1995-09-29 1999-03-20 와다 아키히로 Intake cooling structure in engine room
KR20040012717A (en) 2001-01-25 2004-02-11 발리오 리미티드 Combination of probiotics
KR20120023480A (en) * 2010-08-16 2012-03-13 건국대학교 산학협력단 (a novel lactobacillus plantarum, composition with antibacterial and antioxidant activity comprising the same and use of thereof
KR101960189B1 (en) * 2017-10-25 2019-03-19 건국대학교 산학협력단 NOVEL STRAIN OF Lactobacillus plantarum AND USE THEREOF
KR20190103755A (en) * 2018-02-28 2019-09-05 건국대학교 산학협력단 Novel Lactobacillus plantarum strain and Uses thereof
KR102028744B1 (en) 2018-07-23 2019-10-07 주식회사한국야쿠르트 Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof
KR20180128367A (en) * 2018-11-19 2018-12-03 대구대학교 산학협력단 Kimchi containing fermentation composition using novel lactic acid bacteria Lactobacillus plantarum DGK-17(KACC 81028BP) isolated from Kimchi
KR102033439B1 (en) 2018-11-19 2019-10-17 대구대학교 산학협력단 Kimchi containing fermentation composition using novel lactic acid bacteria Lactobacillus plantarum DGK-17(KACC 81028BP) isolated from Kimchi

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Food Sci. Nutr., Vol.7, pp.2505-2516(2019.08.15.)* *
Genbank Accession No.MH707244.1(2018.08.08.)* *
J. Microbiol. Biotech. Food Sci., Vol.9, pp.516-520(2019.12.01.)* *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102457366B1 (en) * 2021-09-30 2022-10-21 한국식품연구원 Lactobacillus plantarum wikim0127 strain derived from jeju pickled cabbage food and method for preparing composition using same
KR102457367B1 (en) * 2021-09-30 2022-10-24 한국식품연구원 Lactobacillus plantarum wikim0126 strain derived from jeju pickled brussels sprout food and method for preparing composition using same
KR20230172285A (en) * 2022-06-15 2023-12-22 콜마비앤에이치 주식회사 Novel Lactiplantibacillus plantarum SKO-001 and use thereof
KR102620909B1 (en) 2022-06-15 2024-01-04 콜마비앤에이치 주식회사 Novel Lactiplantibacillus plantarum SKO-001 and use thereof

Similar Documents

Publication Publication Date Title
Aarti et al. In vitro studies on probiotic and antioxidant properties of Lactobacillus brevis strain LAP2 isolated from Hentak, a fermented fish product of North-East India
KR102028744B1 (en) Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof
KR101452234B1 (en) Novel Lactobacillus fermentum isolated from healthy adults in the Korean longevity villages which promote regular bowel movement
EP2435056B1 (en) Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
KR102254751B1 (en) New Lactobacillus plantarum WiKim83 and use thereof
AU2011302135B2 (en) Bacillus subtilis isolate from corn
KR102238633B1 (en) Novel Lactobacillus plantarum strain and Uses thereof
KR101825836B1 (en) Novel Lactobacillus plantarum Lb41 strain and compositions for the prevention and treatment of diabetes or insulin resistance syndrome containing the same
KR101868517B1 (en) Lactobacillus fermentum PL9119 with biofunctional activities and high heat stability as a probiotic without antibiotic resistance
KR102191774B1 (en) Novel Lactobacillus plantarum MKHA11 and uses thereof
US9814242B2 (en) Bacillus subtilis isolate from corn and extracts that inhibit the growth of undesirable microorganisms in food products
KR101634270B1 (en) Lactobacillus plantarum jsa22 strain and composition comprising the same
KR102294445B1 (en) Infant and child origin lactic acid bacteria Lactobacillus paracasei MG4592 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
KR101960352B1 (en) Lactobacillus brevis SBB07 strain from fermented berry having antimicrobial activity against pathogenic microorganism, antibiotic resistance activity, antioxidant activity, enzyme secretion activity, acid resistance activity, bile resistance activity, heat resistance activity, prebiotics substrate availability and not producing biogenic amine and uses thereof
KR101839374B1 (en) Bacillus subtilis SCGB 574 strain having antimicrobial activity and probiotics properties and uses thereof
KR102001994B1 (en) Pediococcus pentosaceus SRCM102736 strain having immunity activity, antiviral activity and probiotics properties and uses thereof
KR20200056897A (en) Lactobacillus paracasei SRCM102343 strain having antimicrobial activity and probiotics property and uses thereof
KR102191775B1 (en) Novel Lactobacillus plantarum MKHA15 and uses thereof
KR101993617B1 (en) Lactobacillus pentosus SRCM101105 strain having antimicrobial activity and probiotics properties and uses thereof
KR20190063795A (en) Method for producing aronia fermentation product using Lactobacillus plantarum MIFI-SY3 strain
KR102294442B1 (en) Infant and child origin lactic acid bacteria Lactobacillus plantarum MG4555 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
KR102294437B1 (en) Infant and child origin lactic acid bacteria Lactobacillus plantarum MG4553 and composition comprising the lactic acid bacteria for enhancing intestine activity, anti-oxidant and anti-obesity
KR101488770B1 (en) Lactobacillus fermentum PL9036 isolated from healthy senior citizens in the Korean longevity villages
KR101996080B1 (en) Lactobacillus plantarum SRCM101594 strain having antimicrobial activity and probiotics properties and uses thereof
KR101960189B1 (en) NOVEL STRAIN OF Lactobacillus plantarum AND USE THEREOF

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant